Open-label, comparative and randomised pilot study to evaluate the efficacy and safety of saquinavir/ritonavir in single therapy vs standard HAART therapy as maintenance therapy.
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Ritonavir (Primary) ; Saquinavir (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 12 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Feb 2008 The expected completion date for this trial is now 1 May 2008.